Hi Chair Bedford,
Thank you so much for your thoughtful email and for sharing this cause with Director Stewart. I am so grateful for your support and curiosity! It would mean a lot if the Board of Health can review this effort and I hope this can become a starting point for the potential addition of MLD into the NC Newborn Screening panel.
My interest in the rare disease field began when I first interned at a rare lysosomal disorder lab at Duke Pediatrics summer of sophomore year. As I dug deeper into the research aspect of rare diseases, I also learned about the heath advocacy aspect of it as well especially, Newborn Screening. I learnt that there is a major gap in the treatment and timely diagnosis especially because many treatments work effectively only before the symptoms appear. Newborn Screening stands as a major lifeline for many future families. Ever since then, I have worked on multiple rare disease related projects from conducting research on ultra-rare disorder, NAXE deficiency to coding data collection registries for genetic counselors.
While I do not directly know people impacted by MLD, I do realize the significance of newborn screening in lives of current and prospective parents and patients. MLD stands as in my opinion, one of the most actionable disease to be considered for newborn screening due to 3 main reasons:
1. Implementation is already underway: New York has already implemented universal newborn screening for MLD and Illinois passed legislation for adding MLD in 2023 making it a realistic, adoptable disorder to be added to the newborn screening panel.
2.
Screening Reliability is strong: 500k babies have been tested for MLD with no false negatives or no false positives whatsoever! (
reference link)
3.
There is an FDA approved pre-symptomatic treatment: It has a FDA approved treatment known as Lenmeldy which only works on children before symptoms occur. The children who have been treated with this treatment have so far survived 6 years since the trial while many of the untreated children unfortunately, do not survive this long. (
reference link)
And I certainly agree that the cost of treatments for rare diseases is a major concern. Even Lenmeldy, though one time treatment, stands at $4.25 million dollars! But with newborn screening and research, we are finding out rare diseases really are not as rare as we once thought because many milder or late onset forms get missed but as more people are identified, the chances for increase in federal funding is also increasing. One of the major goals of my nonprofit is to encourage the youth to advocate for Newborn screening as well as Therapy Accessibility.
Please let me know if you need any additional information or have any other questions, I would be more than happy to provide them! Thank you so much again for your time, curiosity, and support! It genuinely means a lot!
With Gratitude,
Vrinda